Global Gene Editing Drug Supply, Demand and Key Producers, 2023-2029
The global Gene Editing Drug market size is expected to reach $ 3274.3 million by 2029, rising at a market growth of 14.2% CAGR during the forecast period (2023-2029).
Gene editing drugs are an innovative biomedical treatment method that treat diseases by directly modifying a patient's genes. These drugs use various gene editing technologies, such as CRISPR-Cas9, ZFN (zinc finger nuclease), to precisely edit the patient's DNA sequence. Overall, the field of gene-editing drugs has great potential to treat a variety of diseases, but the field will continue to evolve and advance as ethical, safety, and legal issues are addressed.
This report studies the global Gene Editing Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Editing Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Editing Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Editing Drug total production and demand, 2018-2029, (K Units)
Global Gene Editing Drug total production value, 2018-2029, (USD Million)
Global Gene Editing Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gene Editing Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Gene Editing Drug domestic production, consumption, key domestic manufacturers and share
Global Gene Editing Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Gene Editing Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gene Editing Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Gene Editing Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Sangamo Therapeutics, Bluebird Bio, Beam Therapeutics, Yaotang Biotechnology, ICamuno Biotherapeutics and Reforgene Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Editing Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene Editing Drug Market, By Region:
1. How big is the global Gene Editing Drug market?
2. What is the demand of the global Gene Editing Drug market?
3. What is the year over year growth of the global Gene Editing Drug market?
4. What is the production and production value of the global Gene Editing Drug market?
5. Who are the key producers in the global Gene Editing Drug market?
Gene editing drugs are an innovative biomedical treatment method that treat diseases by directly modifying a patient's genes. These drugs use various gene editing technologies, such as CRISPR-Cas9, ZFN (zinc finger nuclease), to precisely edit the patient's DNA sequence. Overall, the field of gene-editing drugs has great potential to treat a variety of diseases, but the field will continue to evolve and advance as ethical, safety, and legal issues are addressed.
This report studies the global Gene Editing Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Editing Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Editing Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Editing Drug total production and demand, 2018-2029, (K Units)
Global Gene Editing Drug total production value, 2018-2029, (USD Million)
Global Gene Editing Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gene Editing Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Gene Editing Drug domestic production, consumption, key domestic manufacturers and share
Global Gene Editing Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Gene Editing Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gene Editing Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Gene Editing Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Sangamo Therapeutics, Bluebird Bio, Beam Therapeutics, Yaotang Biotechnology, ICamuno Biotherapeutics and Reforgene Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Editing Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene Editing Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- CRISPR-Cas9 Gene Editing Drugs
- Zinc Finger Nuclease Gene Editing Drugs
- Others
- General Hospital
- Specialty Hospital
- CRISPR Therapeutics
- Editas Medicine
- Intellia Therapeutics
- Sangamo Therapeutics
- Bluebird Bio
- Beam Therapeutics
- Yaotang Biotechnology
- ICamuno Biotherapeutics
- Reforgene Medicine
- Star Eyed Creature
1. How big is the global Gene Editing Drug market?
2. What is the demand of the global Gene Editing Drug market?
3. What is the year over year growth of the global Gene Editing Drug market?
4. What is the production and production value of the global Gene Editing Drug market?
5. Who are the key producers in the global Gene Editing Drug market?
1 SUPPLY SUMMARY
1.1 Gene Editing Drug Introduction
1.2 World Gene Editing Drug Supply & Forecast
1.2.1 World Gene Editing Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Gene Editing Drug Production (2018-2029)
1.2.3 World Gene Editing Drug Pricing Trends (2018-2029)
1.3 World Gene Editing Drug Production by Region (Based on Production Site)
1.3.1 World Gene Editing Drug Production Value by Region (2018-2029)
1.3.2 World Gene Editing Drug Production by Region (2018-2029)
1.3.3 World Gene Editing Drug Average Price by Region (2018-2029)
1.3.4 North America Gene Editing Drug Production (2018-2029)
1.3.5 Europe Gene Editing Drug Production (2018-2029)
1.3.6 China Gene Editing Drug Production (2018-2029)
1.3.7 Japan Gene Editing Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Editing Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Editing Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Gene Editing Drug Demand (2018-2029)
2.2 World Gene Editing Drug Consumption by Region
2.2.1 World Gene Editing Drug Consumption by Region (2018-2023)
2.2.2 World Gene Editing Drug Consumption Forecast by Region (2024-2029)
2.3 United States Gene Editing Drug Consumption (2018-2029)
2.4 China Gene Editing Drug Consumption (2018-2029)
2.5 Europe Gene Editing Drug Consumption (2018-2029)
2.6 Japan Gene Editing Drug Consumption (2018-2029)
2.7 South Korea Gene Editing Drug Consumption (2018-2029)
2.8 ASEAN Gene Editing Drug Consumption (2018-2029)
2.9 India Gene Editing Drug Consumption (2018-2029)
3 WORLD GENE EDITING DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Gene Editing Drug Production Value by Manufacturer (2018-2023)
3.2 World Gene Editing Drug Production by Manufacturer (2018-2023)
3.3 World Gene Editing Drug Average Price by Manufacturer (2018-2023)
3.4 Gene Editing Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Gene Editing Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Gene Editing Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Gene Editing Drug in 2022
3.6 Gene Editing Drug Market: Overall Company Footprint Analysis
3.6.1 Gene Editing Drug Market: Region Footprint
3.6.2 Gene Editing Drug Market: Company Product Type Footprint
3.6.3 Gene Editing Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Gene Editing Drug Production Value Comparison
4.1.1 United States VS China: Gene Editing Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Gene Editing Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Gene Editing Drug Production Comparison
4.2.1 United States VS China: Gene Editing Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene Editing Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Gene Editing Drug Consumption Comparison
4.3.1 United States VS China: Gene Editing Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Gene Editing Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Gene Editing Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Gene Editing Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Gene Editing Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Gene Editing Drug Production (2018-2023)
4.5 China Based Gene Editing Drug Manufacturers and Market Share
4.5.1 China Based Gene Editing Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Gene Editing Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Gene Editing Drug Production (2018-2023)
4.6 Rest of World Based Gene Editing Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Gene Editing Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Gene Editing Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Gene Editing Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Editing Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CRISPR-Cas9 Gene Editing Drugs
5.2.2 Zinc Finger Nuclease Gene Editing Drugs
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Gene Editing Drug Production by Type (2018-2029)
5.3.2 World Gene Editing Drug Production Value by Type (2018-2029)
5.3.3 World Gene Editing Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Editing Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 General Hospital
6.2.2 Specialty Hospital
6.3 Market Segment by Application
6.3.1 World Gene Editing Drug Production by Application (2018-2029)
6.3.2 World Gene Editing Drug Production Value by Application (2018-2029)
6.3.3 World Gene Editing Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 CRISPR Therapeutics
7.1.1 CRISPR Therapeutics Details
7.1.2 CRISPR Therapeutics Major Business
7.1.3 CRISPR Therapeutics Gene Editing Drug Product and Services
7.1.4 CRISPR Therapeutics Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 CRISPR Therapeutics Recent Developments/Updates
7.1.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
7.2 Editas Medicine
7.2.1 Editas Medicine Details
7.2.2 Editas Medicine Major Business
7.2.3 Editas Medicine Gene Editing Drug Product and Services
7.2.4 Editas Medicine Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Editas Medicine Recent Developments/Updates
7.2.6 Editas Medicine Competitive Strengths & Weaknesses
7.3 Intellia Therapeutics
7.3.1 Intellia Therapeutics Details
7.3.2 Intellia Therapeutics Major Business
7.3.3 Intellia Therapeutics Gene Editing Drug Product and Services
7.3.4 Intellia Therapeutics Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Intellia Therapeutics Recent Developments/Updates
7.3.6 Intellia Therapeutics Competitive Strengths & Weaknesses
7.4 Sangamo Therapeutics
7.4.1 Sangamo Therapeutics Details
7.4.2 Sangamo Therapeutics Major Business
7.4.3 Sangamo Therapeutics Gene Editing Drug Product and Services
7.4.4 Sangamo Therapeutics Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sangamo Therapeutics Recent Developments/Updates
7.4.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
7.5 Bluebird Bio
7.5.1 Bluebird Bio Details
7.5.2 Bluebird Bio Major Business
7.5.3 Bluebird Bio Gene Editing Drug Product and Services
7.5.4 Bluebird Bio Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Bluebird Bio Recent Developments/Updates
7.5.6 Bluebird Bio Competitive Strengths & Weaknesses
7.6 Beam Therapeutics
7.6.1 Beam Therapeutics Details
7.6.2 Beam Therapeutics Major Business
7.6.3 Beam Therapeutics Gene Editing Drug Product and Services
7.6.4 Beam Therapeutics Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Beam Therapeutics Recent Developments/Updates
7.6.6 Beam Therapeutics Competitive Strengths & Weaknesses
7.7 Yaotang Biotechnology
7.7.1 Yaotang Biotechnology Details
7.7.2 Yaotang Biotechnology Major Business
7.7.3 Yaotang Biotechnology Gene Editing Drug Product and Services
7.7.4 Yaotang Biotechnology Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Yaotang Biotechnology Recent Developments/Updates
7.7.6 Yaotang Biotechnology Competitive Strengths & Weaknesses
7.8 ICamuno Biotherapeutics
7.8.1 ICamuno Biotherapeutics Details
7.8.2 ICamuno Biotherapeutics Major Business
7.8.3 ICamuno Biotherapeutics Gene Editing Drug Product and Services
7.8.4 ICamuno Biotherapeutics Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 ICamuno Biotherapeutics Recent Developments/Updates
7.8.6 ICamuno Biotherapeutics Competitive Strengths & Weaknesses
7.9 Reforgene Medicine
7.9.1 Reforgene Medicine Details
7.9.2 Reforgene Medicine Major Business
7.9.3 Reforgene Medicine Gene Editing Drug Product and Services
7.9.4 Reforgene Medicine Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Reforgene Medicine Recent Developments/Updates
7.9.6 Reforgene Medicine Competitive Strengths & Weaknesses
7.10 Star Eyed Creature
7.10.1 Star Eyed Creature Details
7.10.2 Star Eyed Creature Major Business
7.10.3 Star Eyed Creature Gene Editing Drug Product and Services
7.10.4 Star Eyed Creature Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Star Eyed Creature Recent Developments/Updates
7.10.6 Star Eyed Creature Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Editing Drug Industry Chain
8.2 Gene Editing Drug Upstream Analysis
8.2.1 Gene Editing Drug Core Raw Materials
8.2.2 Main Manufacturers of Gene Editing Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Gene Editing Drug Production Mode
8.6 Gene Editing Drug Procurement Model
8.7 Gene Editing Drug Industry Sales Model and Sales Channels
8.7.1 Gene Editing Drug Sales Model
8.7.2 Gene Editing Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Gene Editing Drug Introduction
1.2 World Gene Editing Drug Supply & Forecast
1.2.1 World Gene Editing Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Gene Editing Drug Production (2018-2029)
1.2.3 World Gene Editing Drug Pricing Trends (2018-2029)
1.3 World Gene Editing Drug Production by Region (Based on Production Site)
1.3.1 World Gene Editing Drug Production Value by Region (2018-2029)
1.3.2 World Gene Editing Drug Production by Region (2018-2029)
1.3.3 World Gene Editing Drug Average Price by Region (2018-2029)
1.3.4 North America Gene Editing Drug Production (2018-2029)
1.3.5 Europe Gene Editing Drug Production (2018-2029)
1.3.6 China Gene Editing Drug Production (2018-2029)
1.3.7 Japan Gene Editing Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Editing Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Editing Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Gene Editing Drug Demand (2018-2029)
2.2 World Gene Editing Drug Consumption by Region
2.2.1 World Gene Editing Drug Consumption by Region (2018-2023)
2.2.2 World Gene Editing Drug Consumption Forecast by Region (2024-2029)
2.3 United States Gene Editing Drug Consumption (2018-2029)
2.4 China Gene Editing Drug Consumption (2018-2029)
2.5 Europe Gene Editing Drug Consumption (2018-2029)
2.6 Japan Gene Editing Drug Consumption (2018-2029)
2.7 South Korea Gene Editing Drug Consumption (2018-2029)
2.8 ASEAN Gene Editing Drug Consumption (2018-2029)
2.9 India Gene Editing Drug Consumption (2018-2029)
3 WORLD GENE EDITING DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Gene Editing Drug Production Value by Manufacturer (2018-2023)
3.2 World Gene Editing Drug Production by Manufacturer (2018-2023)
3.3 World Gene Editing Drug Average Price by Manufacturer (2018-2023)
3.4 Gene Editing Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Gene Editing Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Gene Editing Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Gene Editing Drug in 2022
3.6 Gene Editing Drug Market: Overall Company Footprint Analysis
3.6.1 Gene Editing Drug Market: Region Footprint
3.6.2 Gene Editing Drug Market: Company Product Type Footprint
3.6.3 Gene Editing Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Gene Editing Drug Production Value Comparison
4.1.1 United States VS China: Gene Editing Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Gene Editing Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Gene Editing Drug Production Comparison
4.2.1 United States VS China: Gene Editing Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene Editing Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Gene Editing Drug Consumption Comparison
4.3.1 United States VS China: Gene Editing Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Gene Editing Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Gene Editing Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Gene Editing Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Gene Editing Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Gene Editing Drug Production (2018-2023)
4.5 China Based Gene Editing Drug Manufacturers and Market Share
4.5.1 China Based Gene Editing Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Gene Editing Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Gene Editing Drug Production (2018-2023)
4.6 Rest of World Based Gene Editing Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Gene Editing Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Gene Editing Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Gene Editing Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Editing Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CRISPR-Cas9 Gene Editing Drugs
5.2.2 Zinc Finger Nuclease Gene Editing Drugs
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Gene Editing Drug Production by Type (2018-2029)
5.3.2 World Gene Editing Drug Production Value by Type (2018-2029)
5.3.3 World Gene Editing Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Editing Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 General Hospital
6.2.2 Specialty Hospital
6.3 Market Segment by Application
6.3.1 World Gene Editing Drug Production by Application (2018-2029)
6.3.2 World Gene Editing Drug Production Value by Application (2018-2029)
6.3.3 World Gene Editing Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 CRISPR Therapeutics
7.1.1 CRISPR Therapeutics Details
7.1.2 CRISPR Therapeutics Major Business
7.1.3 CRISPR Therapeutics Gene Editing Drug Product and Services
7.1.4 CRISPR Therapeutics Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 CRISPR Therapeutics Recent Developments/Updates
7.1.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
7.2 Editas Medicine
7.2.1 Editas Medicine Details
7.2.2 Editas Medicine Major Business
7.2.3 Editas Medicine Gene Editing Drug Product and Services
7.2.4 Editas Medicine Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Editas Medicine Recent Developments/Updates
7.2.6 Editas Medicine Competitive Strengths & Weaknesses
7.3 Intellia Therapeutics
7.3.1 Intellia Therapeutics Details
7.3.2 Intellia Therapeutics Major Business
7.3.3 Intellia Therapeutics Gene Editing Drug Product and Services
7.3.4 Intellia Therapeutics Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Intellia Therapeutics Recent Developments/Updates
7.3.6 Intellia Therapeutics Competitive Strengths & Weaknesses
7.4 Sangamo Therapeutics
7.4.1 Sangamo Therapeutics Details
7.4.2 Sangamo Therapeutics Major Business
7.4.3 Sangamo Therapeutics Gene Editing Drug Product and Services
7.4.4 Sangamo Therapeutics Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sangamo Therapeutics Recent Developments/Updates
7.4.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
7.5 Bluebird Bio
7.5.1 Bluebird Bio Details
7.5.2 Bluebird Bio Major Business
7.5.3 Bluebird Bio Gene Editing Drug Product and Services
7.5.4 Bluebird Bio Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Bluebird Bio Recent Developments/Updates
7.5.6 Bluebird Bio Competitive Strengths & Weaknesses
7.6 Beam Therapeutics
7.6.1 Beam Therapeutics Details
7.6.2 Beam Therapeutics Major Business
7.6.3 Beam Therapeutics Gene Editing Drug Product and Services
7.6.4 Beam Therapeutics Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Beam Therapeutics Recent Developments/Updates
7.6.6 Beam Therapeutics Competitive Strengths & Weaknesses
7.7 Yaotang Biotechnology
7.7.1 Yaotang Biotechnology Details
7.7.2 Yaotang Biotechnology Major Business
7.7.3 Yaotang Biotechnology Gene Editing Drug Product and Services
7.7.4 Yaotang Biotechnology Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Yaotang Biotechnology Recent Developments/Updates
7.7.6 Yaotang Biotechnology Competitive Strengths & Weaknesses
7.8 ICamuno Biotherapeutics
7.8.1 ICamuno Biotherapeutics Details
7.8.2 ICamuno Biotherapeutics Major Business
7.8.3 ICamuno Biotherapeutics Gene Editing Drug Product and Services
7.8.4 ICamuno Biotherapeutics Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 ICamuno Biotherapeutics Recent Developments/Updates
7.8.6 ICamuno Biotherapeutics Competitive Strengths & Weaknesses
7.9 Reforgene Medicine
7.9.1 Reforgene Medicine Details
7.9.2 Reforgene Medicine Major Business
7.9.3 Reforgene Medicine Gene Editing Drug Product and Services
7.9.4 Reforgene Medicine Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Reforgene Medicine Recent Developments/Updates
7.9.6 Reforgene Medicine Competitive Strengths & Weaknesses
7.10 Star Eyed Creature
7.10.1 Star Eyed Creature Details
7.10.2 Star Eyed Creature Major Business
7.10.3 Star Eyed Creature Gene Editing Drug Product and Services
7.10.4 Star Eyed Creature Gene Editing Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Star Eyed Creature Recent Developments/Updates
7.10.6 Star Eyed Creature Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Editing Drug Industry Chain
8.2 Gene Editing Drug Upstream Analysis
8.2.1 Gene Editing Drug Core Raw Materials
8.2.2 Main Manufacturers of Gene Editing Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Gene Editing Drug Production Mode
8.6 Gene Editing Drug Procurement Model
8.7 Gene Editing Drug Industry Sales Model and Sales Channels
8.7.1 Gene Editing Drug Sales Model
8.7.2 Gene Editing Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Gene Editing Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Gene Editing Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Gene Editing Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Gene Editing Drug Production Value Market Share by Region (2018-2023)
Table 5. World Gene Editing Drug Production Value Market Share by Region (2024-2029)
Table 6. World Gene Editing Drug Production by Region (2018-2023) & (K Units)
Table 7. World Gene Editing Drug Production by Region (2024-2029) & (K Units)
Table 8. World Gene Editing Drug Production Market Share by Region (2018-2023)
Table 9. World Gene Editing Drug Production Market Share by Region (2024-2029)
Table 10. World Gene Editing Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Gene Editing Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Gene Editing Drug Major Market Trends
Table 13. World Gene Editing Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Gene Editing Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Gene Editing Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Gene Editing Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Gene Editing Drug Producers in 2022
Table 18. World Gene Editing Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Gene Editing Drug Producers in 2022
Table 20. World Gene Editing Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Gene Editing Drug Company Evaluation Quadrant
Table 22. World Gene Editing Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Gene Editing Drug Production Site of Key Manufacturer
Table 24. Gene Editing Drug Market: Company Product Type Footprint
Table 25. Gene Editing Drug Market: Company Product Application Footprint
Table 26. Gene Editing Drug Competitive Factors
Table 27. Gene Editing Drug New Entrant and Capacity Expansion Plans
Table 28. Gene Editing Drug Mergers & Acquisitions Activity
Table 29. United States VS China Gene Editing Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Gene Editing Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Gene Editing Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Gene Editing Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Gene Editing Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Gene Editing Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Gene Editing Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Gene Editing Drug Production Market Share (2018-2023)
Table 37. China Based Gene Editing Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Gene Editing Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Gene Editing Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Gene Editing Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Gene Editing Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Gene Editing Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Gene Editing Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Gene Editing Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Gene Editing Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Gene Editing Drug Production Market Share (2018-2023)
Table 47. World Gene Editing Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Gene Editing Drug Production by Type (2018-2023) & (K Units)
Table 49. World Gene Editing Drug Production by Type (2024-2029) & (K Units)
Table 50. World Gene Editing Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Gene Editing Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Gene Editing Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Gene Editing Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Gene Editing Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Gene Editing Drug Production by Application (2018-2023) & (K Units)
Table 56. World Gene Editing Drug Production by Application (2024-2029) & (K Units)
Table 57. World Gene Editing Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Gene Editing Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Gene Editing Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Gene Editing Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. CRISPR Therapeutics Major Business
Table 63. CRISPR Therapeutics Gene Editing Drug Product and Services
Table 64. CRISPR Therapeutics Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. CRISPR Therapeutics Recent Developments/Updates
Table 66. CRISPR Therapeutics Competitive Strengths & Weaknesses
Table 67. Editas Medicine Basic Information, Manufacturing Base and Competitors
Table 68. Editas Medicine Major Business
Table 69. Editas Medicine Gene Editing Drug Product and Services
Table 70. Editas Medicine Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Editas Medicine Recent Developments/Updates
Table 72. Editas Medicine Competitive Strengths & Weaknesses
Table 73. Intellia Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. Intellia Therapeutics Major Business
Table 75. Intellia Therapeutics Gene Editing Drug Product and Services
Table 76. Intellia Therapeutics Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Intellia Therapeutics Recent Developments/Updates
Table 78. Intellia Therapeutics Competitive Strengths & Weaknesses
Table 79. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. Sangamo Therapeutics Major Business
Table 81. Sangamo Therapeutics Gene Editing Drug Product and Services
Table 82. Sangamo Therapeutics Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sangamo Therapeutics Recent Developments/Updates
Table 84. Sangamo Therapeutics Competitive Strengths & Weaknesses
Table 85. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 86. Bluebird Bio Major Business
Table 87. Bluebird Bio Gene Editing Drug Product and Services
Table 88. Bluebird Bio Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Bluebird Bio Recent Developments/Updates
Table 90. Bluebird Bio Competitive Strengths & Weaknesses
Table 91. Beam Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Beam Therapeutics Major Business
Table 93. Beam Therapeutics Gene Editing Drug Product and Services
Table 94. Beam Therapeutics Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Beam Therapeutics Recent Developments/Updates
Table 96. Beam Therapeutics Competitive Strengths & Weaknesses
Table 97. Yaotang Biotechnology Basic Information, Manufacturing Base and Competitors
Table 98. Yaotang Biotechnology Major Business
Table 99. Yaotang Biotechnology Gene Editing Drug Product and Services
Table 100. Yaotang Biotechnology Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Yaotang Biotechnology Recent Developments/Updates
Table 102. Yaotang Biotechnology Competitive Strengths & Weaknesses
Table 103. ICamuno Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 104. ICamuno Biotherapeutics Major Business
Table 105. ICamuno Biotherapeutics Gene Editing Drug Product and Services
Table 106. ICamuno Biotherapeutics Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. ICamuno Biotherapeutics Recent Developments/Updates
Table 108. ICamuno Biotherapeutics Competitive Strengths & Weaknesses
Table 109. Reforgene Medicine Basic Information, Manufacturing Base and Competitors
Table 110. Reforgene Medicine Major Business
Table 111. Reforgene Medicine Gene Editing Drug Product and Services
Table 112. Reforgene Medicine Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Reforgene Medicine Recent Developments/Updates
Table 114. Star Eyed Creature Basic Information, Manufacturing Base and Competitors
Table 115. Star Eyed Creature Major Business
Table 116. Star Eyed Creature Gene Editing Drug Product and Services
Table 117. Star Eyed Creature Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Gene Editing Drug Upstream (Raw Materials)
Table 119. Gene Editing Drug Typical Customers
Table 120. Gene Editing Drug Typical Distributors
LIST OF FIGURE
Figure 1. Gene Editing Drug Picture
Figure 2. World Gene Editing Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene Editing Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Gene Editing Drug Production (2018-2029) & (K Units)
Figure 5. World Gene Editing Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Gene Editing Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Gene Editing Drug Production Market Share by Region (2018-2029)
Figure 8. North America Gene Editing Drug Production (2018-2029) & (K Units)
Figure 9. Europe Gene Editing Drug Production (2018-2029) & (K Units)
Figure 10. China Gene Editing Drug Production (2018-2029) & (K Units)
Figure 11. Japan Gene Editing Drug Production (2018-2029) & (K Units)
Figure 12. Gene Editing Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 15. World Gene Editing Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 17. China Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 22. India Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Gene Editing Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Gene Editing Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Gene Editing Drug Markets in 2022
Figure 26. United States VS China: Gene Editing Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Gene Editing Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene Editing Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Gene Editing Drug Production Market Share 2022
Figure 30. China Based Manufacturers Gene Editing Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Gene Editing Drug Production Market Share 2022
Figure 32. World Gene Editing Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Gene Editing Drug Production Value Market Share by Type in 2022
Figure 34. CRISPR-Cas9 Gene Editing Drugs
Figure 35. Zinc Finger Nuclease Gene Editing Drugs
Figure 36. Others
Figure 37. World Gene Editing Drug Production Market Share by Type (2018-2029)
Figure 38. World Gene Editing Drug Production Value Market Share by Type (2018-2029)
Figure 39. World Gene Editing Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Gene Editing Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Gene Editing Drug Production Value Market Share by Application in 2022
Figure 42. General Hospital
Figure 43. Specialty Hospital
Figure 44. World Gene Editing Drug Production Market Share by Application (2018-2029)
Figure 45. World Gene Editing Drug Production Value Market Share by Application (2018-2029)
Figure 46. World Gene Editing Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Gene Editing Drug Industry Chain
Figure 48. Gene Editing Drug Procurement Model
Figure 49. Gene Editing Drug Sales Model
Figure 50. Gene Editing Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Gene Editing Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Gene Editing Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Gene Editing Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Gene Editing Drug Production Value Market Share by Region (2018-2023)
Table 5. World Gene Editing Drug Production Value Market Share by Region (2024-2029)
Table 6. World Gene Editing Drug Production by Region (2018-2023) & (K Units)
Table 7. World Gene Editing Drug Production by Region (2024-2029) & (K Units)
Table 8. World Gene Editing Drug Production Market Share by Region (2018-2023)
Table 9. World Gene Editing Drug Production Market Share by Region (2024-2029)
Table 10. World Gene Editing Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Gene Editing Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Gene Editing Drug Major Market Trends
Table 13. World Gene Editing Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Gene Editing Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Gene Editing Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Gene Editing Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Gene Editing Drug Producers in 2022
Table 18. World Gene Editing Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Gene Editing Drug Producers in 2022
Table 20. World Gene Editing Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Gene Editing Drug Company Evaluation Quadrant
Table 22. World Gene Editing Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Gene Editing Drug Production Site of Key Manufacturer
Table 24. Gene Editing Drug Market: Company Product Type Footprint
Table 25. Gene Editing Drug Market: Company Product Application Footprint
Table 26. Gene Editing Drug Competitive Factors
Table 27. Gene Editing Drug New Entrant and Capacity Expansion Plans
Table 28. Gene Editing Drug Mergers & Acquisitions Activity
Table 29. United States VS China Gene Editing Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Gene Editing Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Gene Editing Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Gene Editing Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Gene Editing Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Gene Editing Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Gene Editing Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Gene Editing Drug Production Market Share (2018-2023)
Table 37. China Based Gene Editing Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Gene Editing Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Gene Editing Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Gene Editing Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Gene Editing Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Gene Editing Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Gene Editing Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Gene Editing Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Gene Editing Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Gene Editing Drug Production Market Share (2018-2023)
Table 47. World Gene Editing Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Gene Editing Drug Production by Type (2018-2023) & (K Units)
Table 49. World Gene Editing Drug Production by Type (2024-2029) & (K Units)
Table 50. World Gene Editing Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Gene Editing Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Gene Editing Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Gene Editing Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Gene Editing Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Gene Editing Drug Production by Application (2018-2023) & (K Units)
Table 56. World Gene Editing Drug Production by Application (2024-2029) & (K Units)
Table 57. World Gene Editing Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Gene Editing Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Gene Editing Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Gene Editing Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. CRISPR Therapeutics Major Business
Table 63. CRISPR Therapeutics Gene Editing Drug Product and Services
Table 64. CRISPR Therapeutics Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. CRISPR Therapeutics Recent Developments/Updates
Table 66. CRISPR Therapeutics Competitive Strengths & Weaknesses
Table 67. Editas Medicine Basic Information, Manufacturing Base and Competitors
Table 68. Editas Medicine Major Business
Table 69. Editas Medicine Gene Editing Drug Product and Services
Table 70. Editas Medicine Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Editas Medicine Recent Developments/Updates
Table 72. Editas Medicine Competitive Strengths & Weaknesses
Table 73. Intellia Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. Intellia Therapeutics Major Business
Table 75. Intellia Therapeutics Gene Editing Drug Product and Services
Table 76. Intellia Therapeutics Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Intellia Therapeutics Recent Developments/Updates
Table 78. Intellia Therapeutics Competitive Strengths & Weaknesses
Table 79. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. Sangamo Therapeutics Major Business
Table 81. Sangamo Therapeutics Gene Editing Drug Product and Services
Table 82. Sangamo Therapeutics Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sangamo Therapeutics Recent Developments/Updates
Table 84. Sangamo Therapeutics Competitive Strengths & Weaknesses
Table 85. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 86. Bluebird Bio Major Business
Table 87. Bluebird Bio Gene Editing Drug Product and Services
Table 88. Bluebird Bio Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Bluebird Bio Recent Developments/Updates
Table 90. Bluebird Bio Competitive Strengths & Weaknesses
Table 91. Beam Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Beam Therapeutics Major Business
Table 93. Beam Therapeutics Gene Editing Drug Product and Services
Table 94. Beam Therapeutics Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Beam Therapeutics Recent Developments/Updates
Table 96. Beam Therapeutics Competitive Strengths & Weaknesses
Table 97. Yaotang Biotechnology Basic Information, Manufacturing Base and Competitors
Table 98. Yaotang Biotechnology Major Business
Table 99. Yaotang Biotechnology Gene Editing Drug Product and Services
Table 100. Yaotang Biotechnology Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Yaotang Biotechnology Recent Developments/Updates
Table 102. Yaotang Biotechnology Competitive Strengths & Weaknesses
Table 103. ICamuno Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 104. ICamuno Biotherapeutics Major Business
Table 105. ICamuno Biotherapeutics Gene Editing Drug Product and Services
Table 106. ICamuno Biotherapeutics Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. ICamuno Biotherapeutics Recent Developments/Updates
Table 108. ICamuno Biotherapeutics Competitive Strengths & Weaknesses
Table 109. Reforgene Medicine Basic Information, Manufacturing Base and Competitors
Table 110. Reforgene Medicine Major Business
Table 111. Reforgene Medicine Gene Editing Drug Product and Services
Table 112. Reforgene Medicine Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Reforgene Medicine Recent Developments/Updates
Table 114. Star Eyed Creature Basic Information, Manufacturing Base and Competitors
Table 115. Star Eyed Creature Major Business
Table 116. Star Eyed Creature Gene Editing Drug Product and Services
Table 117. Star Eyed Creature Gene Editing Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Gene Editing Drug Upstream (Raw Materials)
Table 119. Gene Editing Drug Typical Customers
Table 120. Gene Editing Drug Typical Distributors
LIST OF FIGURE
Figure 1. Gene Editing Drug Picture
Figure 2. World Gene Editing Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene Editing Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Gene Editing Drug Production (2018-2029) & (K Units)
Figure 5. World Gene Editing Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Gene Editing Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Gene Editing Drug Production Market Share by Region (2018-2029)
Figure 8. North America Gene Editing Drug Production (2018-2029) & (K Units)
Figure 9. Europe Gene Editing Drug Production (2018-2029) & (K Units)
Figure 10. China Gene Editing Drug Production (2018-2029) & (K Units)
Figure 11. Japan Gene Editing Drug Production (2018-2029) & (K Units)
Figure 12. Gene Editing Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 15. World Gene Editing Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 17. China Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 22. India Gene Editing Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Gene Editing Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Gene Editing Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Gene Editing Drug Markets in 2022
Figure 26. United States VS China: Gene Editing Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Gene Editing Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene Editing Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Gene Editing Drug Production Market Share 2022
Figure 30. China Based Manufacturers Gene Editing Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Gene Editing Drug Production Market Share 2022
Figure 32. World Gene Editing Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Gene Editing Drug Production Value Market Share by Type in 2022
Figure 34. CRISPR-Cas9 Gene Editing Drugs
Figure 35. Zinc Finger Nuclease Gene Editing Drugs
Figure 36. Others
Figure 37. World Gene Editing Drug Production Market Share by Type (2018-2029)
Figure 38. World Gene Editing Drug Production Value Market Share by Type (2018-2029)
Figure 39. World Gene Editing Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Gene Editing Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Gene Editing Drug Production Value Market Share by Application in 2022
Figure 42. General Hospital
Figure 43. Specialty Hospital
Figure 44. World Gene Editing Drug Production Market Share by Application (2018-2029)
Figure 45. World Gene Editing Drug Production Value Market Share by Application (2018-2029)
Figure 46. World Gene Editing Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Gene Editing Drug Industry Chain
Figure 48. Gene Editing Drug Procurement Model
Figure 49. Gene Editing Drug Sales Model
Figure 50. Gene Editing Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
